World Library  
Flag as Inappropriate
Email this Article

High-content screening

Article Id: WHEBN0005824073
Reproduction Date:

Title: High-content screening  
Author: World Heritage Encyclopedia
Language: English
Subject: High throughput biology, Bioimage informatics, Microscopy, Drug discovery, Cellomics
Collection: Drug Discovery, Microscopy
Publisher: World Heritage Encyclopedia

High-content screening

High-content screening (HCS), also known as high-content analysis (HCA) or cellomics, is a method that is used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner.[1][2] Hence high content screening is a type of phenotypic screen conducted in cells. Phenotypic changes may include increases or decreases in the production of cellular products such as proteins and/or changes in the morphology (visual appearance) of the cell. High content screening includes any method used to analyze whole cells or components of cells with simultaneous readout of several parameters. Hence the name "high content screening".[3] Unlike high-content analysis, high-content screening implies a level of throughput which is why the term "screening" differentiates HCS from HCA, which may be high in content but low in throughput.

In high content screening, cells are first

  • Guidelines for Image-Based High Content Screening - NCBI

External links

  • Abraham VC, Taylor DL, Haskins JR (January 2004). "High content screening applied to large-scale cell biology". Trends Biotechnol. 22 (1): 15–22.  
  • Bleicher KH, Böhm HJ, Müller K, Alanine AI (May 2003). "Hit and lead generation: beyond high-throughput screening". Nat Rev Drug Discov 2 (5): 369–78.  
  • Burdine L, Kodadek T (May 2004). "Target identification in chemical genetics: the (often) missing link". Chem. Biol. 11 (5): 593–7.  
  • Carpenter AE, Sabatini DM (January 2004). "Systematic genome-wide screens of gene function". Nat. Rev. Genet. 5 (1): 11–22.  
  • Edwards BS, Oprea T, Prossnitz ER, Sklar LA (August 2004). "Flow cytometry for high-throughput, high-content screening". Curr Opin Chem Biol 8 (4): 392–8.  
  • Xu GW, Mawji IA, Macrae CJ, Koch CA, Datti A, Wrana JL, Dennis JW, Schimmer AD (March 2008). "A high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization". Apoptosis 13 (3): 413–22.  
  • Giuliano KA, Haskins JR, Taylor DL (August 2003). "Advances in high content screening for drug discovery". Assay Drug Dev Technol 1 (4): 565–77.  
  • Liszewski, Kathy (2014). "High Content Analysis: The ‘Just Right’ Solution". Gen. Eng. Biotechnol. News 34 (3). 
  • Milligan G (July 2003). "High-content assays for ligand regulation of G-protein-coupled receptors". Drug Discov. Today 8 (13): 579–85.  
  • Battich N, Stoeger T, Pelkmans L (October 2013). "Image-based transcriptomics in thousands of single human cells at single-molecule resolution". Nature Methods 10 (11): 1127–1133.  

Further reading

  1. ^ Haney SA, ed. (2008). High content screening: science, techniques and applications. New York: Wiley-Interscience.  
  2. ^ Giuliano KA, Haskins JR, ed. (2010). High Content Screening: A Powerful Approach to Systems Cell Biology and Drug Discovery. Totowa, NJ: Humana Press.  
  3. ^ Gasparri F (June 2009). "An overview of cell phenotypes in HCS: limitations and advantages". Expert Opinion on Drug Discovery 4 (6): 643–657.  
  4. ^ Proll G, Steinle L, Pröll F, Kumpf M, Moehrle B, Mehlmann M, Gauglitz G (August 2007). "Potential of label-free detection in high-content-screening applications". J Chromatogr A 1161 (1-2): 2–8.  
  5. ^ Burdine L, Kodadek T (May 2004). "Target identification in chemical genetics: The (often) missing link". Chem. Biol. 11 (5): 593–7.  
  6. ^ Eggert US, Mitchison TJ (June 2006). "Small molecule screening by imaging". Curr Opin Chem Biol 10 (3): 232–7.  


See also

By analogy, if one imagines a football field and dinner plates laid across it, instead of looking at all of them, the investigator would choose a handful near the score line and had to leave the rest. In this analogy the field is a tissue culture dish, the plates the cells growing on it. While this was a reasonable and pragmatic approach automation of the whole process and the analysis makes possible the analysis of the whole population of living cells, so the whole football field can be measured.

In review, classical 20th century cell biology used cell lines grown in culture where the experiments were measured using very similar to that described here, but there the investigator made the choice on what was measured and how. In the early 1990s, the development of CCD cameras (charge coupled device cameras) for research created the opportunity to measure features in pictures of cells- such as how much protein is in the nucleus, how much is outside. Sophisticated measurements soon followed using new fluorescent molecules, which are used to measure cell properties like second messenger concentrations or the pH of internal cell compartments. The wide use of the green fluorescent protein, a natural fluorescent protein molecule from jellyfish, then accelerated the trend toward cell imaging as a mainstream technology in cell biology. Despite these advances, the choice of which cell to image and which data to present and how to analyze it was still selected by the investigator.

For cell-based approaches the utility of automated cell biology requires an examination of how automation and objective measurement can improve the experimentation and the understanding of disease. First, it removes the influence of the investigator in most, but not all, aspects of cell biology research and second it makes entirely new approaches possible.

High-content screening technology allows for the evaluation of multiple biochemical and morphological parameters in intact biological systems.

History This technology allows a (very) large number of experiments to be performed, allowing explorative screening. Cell-based systems are mainly used in chemical genetics where large, diverse small molecule collections are systematically tested for their effect on cellular model systems. Novel drugs can be found using screens of tens of thousands of molecules, and these have promise for the future of drug development. Beyond drug discovery, chemical genetics is aimed at functionalizing the genome by identifying small molecules that acts on most of the 21,000 gene products in a cell. High-content technology will be part of this effort which could provide useful tools for learning where and when proteins act by knocking them out chemically. This would be most useful for gene where knock out mice (missing one or several genes) can not be made because the protein is required for development, growth or otherwise lethal when it is not there. Chemical knock out could address how and where these genes work. Further the technology is used in combination with


Many screens are analyzed using the image analysis software that accompanies the instrument, providing a turn-key solution. Third-party software alternatives are often used for particularly challenging screens or where a laboratory or facility has multiple instruments and wishes to standardize to a single analysis platform. Some instrument software provides bulk importing and exporting of images and data, for users who want to do such standardization on a single analysis platform without the use of third-party software, however.


What all instruments share is the ability to take, store and interpret images automatically and integrate into large robotic cell/medium handling platforms.

HCS instruments on the market today can be separated based on an array of specifications that significantly influence the instruments versatility and overall cost. These include speed, a live cell chamber that includes temperature and CO2 control (some also have humidity control for longer term live cell imaging), a built in pipettor or injector for fast kinetic assays, and additional imaging modes such as confocal, bright field, phase contrast and FRET. One of the most incisive difference is whether the instruments are optical confocal or not. Confocal microscopy summarizes as imaging/resolving a thin slice through an object and rejecting out of focus light that comes from outside this slice. Confocal imaging enables higher image signal to noise and higher resolution than the more commonly applied epi-fluorescence microscopy. Depending on the instrument confocality is achieved via laser scanning, a single spinning disk with pinholes or slits, a dual spinning disk, or a virtual slit. There are trade offs of sensitivity, resolution, speed, photo-toxicity, photo-bleaching, instrument complexity, and price between these various confocal techniques.

High-content screening technology is mainly based on automated digital microscopy and flow cytometry, in combination with IT-systems for the analysis and storage of the data. “High-content” or visual biology technology has two purposes, first to acquire spatially or temporally resolved information on an event and second to automatically quantify it. Spatially resolved instruments are typically automated microscopes, and temporal resolution still requires some form of fluorescence measurement in most cases.This means that a lot of HCS instruments are (fluorescence) microscopes that are connected to some form of image analysis package. These take care of all the steps in taking fluorescent images of cells and provide rapid, automated and unbiased assessment of experiments.

An automated confocal image reader


Automated image based screening permits the identification of small compounds altering cellular phenotypes and is of interest for the discovery of new pharmaceuticals and new cell biological tools for modifying cell function. The selection of molecules based on a cellular phenotype does not require a prior knowledge of the biochemical targets that are affected by compounds. However the identification of the biological target will make subsequent preclinical optimization and clinical development of the compound hit significantly easier. Given the increase in the use of phenotypic/visual screening as a cell biological tool, methods are required that permit systematic biochemical target identification if these molecules are to be of broad use.[5] Target identification has been defined as the rate limiting step in chemical genetics/high-content screening.[6]

At a cellular level, parallel acquisition of data on different cell properties, for example activity of signal transduction cascades and cytoskeleton integrity is the main advantage of this method in comparison to the faster but less detailed high throughput screening. While HCS is slower, the wealth of acquired data allows a more profound understanding of drug effects.

The technology may be used to determine whether a potential drug is disease modifying. For example, in humans G-protein coupled receptors (GPCRs) are a large family of around 880 cell surface proteins that transduce extra-cellular changes in the environment into a cell response, like triggering an increase in blood pressure because of the release of a regulatory hormone into the blood stream. Activation of these GPCRs can involve their entry into cells and when this can be visualised it can be the basis of a systematic analysis of receptor function through chemical genetics, systematic genome wide screening or physiological manipulation.

High-content screening (HCS) in cell-based systems uses living cells as tools in biological research to elucidate the workings of normal and diseased cells. HCS is also used to discover and optimizes new drug candidates. High content screening is a combination of modern cell biology, with all its molecular tools, with automated high resolution microscopy and robotic handling. Cells are first exposed to chemicals or RNAi reagents. Changes in cell morphology are then detected using image analysis. Changes in the amounts of proteins synthesized by cells are measured using a variety of techniques such as the green fluorescent proteins fused to endogenous proteins, or by fluorescent antibodies.

One of the applications of HCS is the discovery of new drug candidates

General principles


  • General principles 1
  • Instrumentation 2
  • Software 3
  • Applications 4
  • History 5
  • See also 6
  • References 7
  • Further reading 8
  • External links 9


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.